Status:
RECRUITING
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institutes of Health (NIH)
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Prospective, interventional cohort study of drug-induced sleep endoscopy (DISE) to evaluate the upper airway in a cohort of obstructive sleep apnea (OSA) surgical patients. This study has investigated...
Eligibility Criteria
Inclusion
- Adult patients with OSA considering surgical treatment
Exclusion
- Minors
- Pregnant women
- Patients unable to provide informed consent in English themselves
- Prisoners
- Allergy to propofol, soybean oil, egg lecithin or glycerol
- Other contraindication to use of propofol (decision of anesthesiologist or otolaryngologist.)
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00695214
Start Date
February 1 2004
End Date
June 1 2030
Last Update
July 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Santa Monica Medical Center
Santa Monica, California, United States, 90401